224 related articles for article (PubMed ID: 31255656)
1. Pre-clinical study of iron oxide nanoparticles fortified artesunate for efficient targeting of malarial parasite.
Kannan D; Yadav N; Ahmad S; Namdev P; Bhattacharjee S; Lochab B; Singh S
EBioMedicine; 2019 Jul; 45():261-277. PubMed ID: 31255656
[TBL] [Abstract][Full Text] [Related]
2. Viability Screen of LOPAC
Tong JX; Ang SEL; Tan EHN; Tan KSW
Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30718250
[TBL] [Abstract][Full Text] [Related]
3. 4-chloro eugenol interacts synergistically with artesunate against drug resistant P. falciparum inducing oxidative stress.
Mina PR; Kumar S; Agarwal K; Kumar R; Pal A; Tandon S; Yadav SK; Yadav S; Darokar MP
Biomed Pharmacother; 2021 May; 137():111311. PubMed ID: 33524782
[TBL] [Abstract][Full Text] [Related]
4. Antiplasmodial profile of selected compounds from Malaria Box: in vitro evaluation, speed of action and drug combination studies.
de Souza GE; Bueno RV; de Souza JO; Zanini CL; Cruz FC; Oliva G; Guido RVC; Aguiar ACC
Malar J; 2019 Dec; 18(1):447. PubMed ID: 31888654
[TBL] [Abstract][Full Text] [Related]
5. Isolation and structure elucidation of a steroidal moiety from
Pradhan D; Biswasroy P; Sahu DK; Ghosh G; Rath G
J Biomol Struct Dyn; 2023 Jul; 41(11):4993-5006. PubMed ID: 35585777
[TBL] [Abstract][Full Text] [Related]
6. High-level artemisinin-resistance with quinine co-resistance emerges in P. falciparum malaria under in vivo artesunate pressure.
Tyagi RK; Gleeson PJ; Arnold L; Tahar R; Prieur E; Decosterd L; Pérignon JL; Olliaro P; Druilhe P
BMC Med; 2018 Oct; 16(1):181. PubMed ID: 30269689
[TBL] [Abstract][Full Text] [Related]
7. [In vitro susceptibility of P. falciparum isolates from Abidjan (Côte d'Ivoire) to quinine, artesunate and chloroquine].
Touré AO; Koné LP; Jambou R; Konan TD; Demba S; Beugre GE; Koné M
Sante; 2008; 18(1):43-7. PubMed ID: 18684691
[TBL] [Abstract][Full Text] [Related]
8. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
9. Monitoring for Plasmodium falciparum drug resistance to artemisinin and artesunate in Binh Phuoc Province, Vietnam: 1998-2009.
Thanh NV; Toan TQ; Cowman AF; Casey GJ; Phuc BQ; Tien NT; Hung NM; Biggs BA
Malar J; 2010 Jun; 9():181. PubMed ID: 20573274
[TBL] [Abstract][Full Text] [Related]
10. Population pharmacokinetic and pharmacodynamic properties of artesunate in patients with artemisinin sensitive and resistant infections in Southern Myanmar.
Lohy Das JP; Kyaw MP; Nyunt MH; Chit K; Aye KH; Aye MM; Karlsson MO; Bergstrand M; Tarning J
Malar J; 2018 Mar; 17(1):126. PubMed ID: 29566683
[TBL] [Abstract][Full Text] [Related]
11. Plasmodium berghei K13 Mutations Mediate
Simwela NV; Stokes BH; Aghabi D; Bogyo M; Fidock DA; Waters AP
mBio; 2020 Nov; 11(6):. PubMed ID: 33173001
[TBL] [Abstract][Full Text] [Related]
12. Considerations on the mechanism of action of artemisinin antimalarials: part 1--the 'carbon radical' and 'heme' hypotheses.
Haynes RK; Cheu KW; N'Da D; Coghi P; Monti D
Infect Disord Drug Targets; 2013 Aug; 13(4):217-77. PubMed ID: 24304352
[TBL] [Abstract][Full Text] [Related]
13. Safety and parasite clearance of artemisinin-resistant Plasmodium falciparum infection: A pilot and a randomised volunteer infection study in Australia.
Watts RE; Odedra A; Marquart L; Webb L; Abd-Rahman AN; Cascales L; Chalon S; Rebelo M; Pava Z; Collins KA; Pasay C; Chen N; Peatey CL; Möhrle JJ; McCarthy JS
PLoS Med; 2020 Aug; 17(8):e1003203. PubMed ID: 32822347
[TBL] [Abstract][Full Text] [Related]
14. Identification of resistance of Plasmodium falciparum to artesunate-mefloquine combination in an area along the Thai-Myanmar border: integration of clinico-parasitological response, systemic drug exposure, and in vitro parasite sensitivity.
Na-Bangchang K; Muhamad P; Ruaengweerayut R; Chaijaroenkul W; Karbwang J
Malar J; 2013 Jul; 12():263. PubMed ID: 23898808
[TBL] [Abstract][Full Text] [Related]
15. Plasmodium falciparum clearance time in Malawian children with cerebral malaria: a retrospective cohort study.
Saidi AM; Guenther G; Izem R; Chen X; Seydel K; Postels D
Malar J; 2021 Oct; 20(1):408. PubMed ID: 34663346
[TBL] [Abstract][Full Text] [Related]
16. Novel halogenated arylvinyl-1,2,4 trioxanes as potent antiplasmodial as well as anticancer agents: Synthesis, bioevaluation, structure-activity relationship and in-silico studies.
Tiwari MK; Coghi P; Agrawal P; Yadav DK; Yang LJ; Congling Q; Sahal D; Wai Wong VK; Chaudhary S
Eur J Med Chem; 2021 Nov; 224():113685. PubMed ID: 34303874
[TBL] [Abstract][Full Text] [Related]
17. Artesunate-amodiaquine and artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in Liberia: in vivo efficacy and frequency of molecular markers.
Koko VS; Warsame M; Vonhm B; Jeuronlon MK; Menard D; Ma L; Taweh F; Tehmeh L; Nyansaiye P; Pratt OJ; Parwon S; Kamara P; Asinya M; Kollie A; Ringwald P
Malar J; 2022 Apr; 21(1):134. PubMed ID: 35477399
[TBL] [Abstract][Full Text] [Related]
18. Artemisinin resistance containment project in Thailand. II: Responses to mefloquine-artesunate combination therapy among falciparum malaria patients in provinces bordering Cambodia.
Satimai W; Sudathip P; Vijaykadga S; Khamsiriwatchara A; Sawang S; Potithavoranan T; Sangvichean A; Delacollette C; Singhasivanon P; Kaewkungwal J; Lawpoolsri S
Malar J; 2012 Aug; 11():300. PubMed ID: 22929621
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of oral and intravenous artesunate in male Tanzanian adults with Plasmodium falciparum malaria and in vitro susceptibility to artemisinin, chloroquine, and mefloquine.
Alin MH; Kihamia CM; Bjorkman A; Bwijo BA; Premji Z; Mtey GJ; Ashton M
Am J Trop Med Hyg; 1995 Dec; 53(6):639-45. PubMed ID: 8561267
[TBL] [Abstract][Full Text] [Related]
20. Highly active ozonides selected against drug resistant malaria.
Lobo L; Sousa Bd; Cabral L; Cristiano ML; Nogueira F
Mem Inst Oswaldo Cruz; 2016 Jun; 0(7):0. PubMed ID: 27276364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
